# Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE

> **NCT06832813** · NA · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Drug-resistant Epilepsy
- Transcranial Magnetic Stimulation

## Interventions

- **DEVICE:** cTBS

## Key facts

- **NCT ID:** NCT06832813
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2027-03-27
- **Final completion:** 2027-03-27
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832813, "Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06832813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*